Xiaohe Liu: Cancer Research Technologies, Discovery Technologiee | SRI International

Toggle Menu

Xiaohe Liu

Research Scientist, Cancer Research Technologies, Discovery Technologies

Xiaohe Liu, Ph.D., M.D., has research interests that include biomarker discovery of circulating tumor cells (CTCs), especially in context with SRI’s Fiber Array Scanning Technology (FASTcell™); development of diagnostics and therapeutics for personalized cancer medicine; and tumor immunology and immunological tolerance.

Liu has more than 15 years of experience in biomedical research, and has published 12 research papers in peer-reviewed journals, including The Journal of Clinical Investigation.

Prior to joining SRI, Liu was a primary scientist for new rare cell applications and cancer biomarker discovery at PARC. Earlier, he completed his postdoctoral training in the School of Medicine at the University of Pennsylvania.

Liu received his M.D. degree from China and his Ph.D. in immunology from Thomas Jefferson University in Philadelphia, Pennsylvania.

View Dr. Liu's selected publications on PubMed. (Search results may include other authors with similar names.)